The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Smoking, nicotine and Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
Cytokines and the nervous system I: expression and recognition
Hopkins, S. J., & Rothwell, N. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80029-2 · Cited by 751
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 639
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585
PRESYNAPTIC IONOTROPIC RECEPTORS AND THE CONTROL OF TRANSMITTER RELEASE
MacDermott, A. B., Role, L. W., & Siegelbaum, S. A. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.443 · Cited by 576
Lukas, R. J., Changeux, J.-P., le Novère, N., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., et al. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01406-6 · Cited by 537
Self-citationClarke, P. B. S., & Pert, A. (1985) · Brain Research · doi:10.1016/0006-8993(85)90456-1 · Cited by 527
Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F. M., Le Novère, N., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 507
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 416
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 405
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
Lotharius, J., Dugan, L. L., & O’Malley, K. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01284.1999 · Cited by 403
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 361
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350
Champtiaux, N., Han, Z.-Y., Bessis, A., Rossi, F. M., Zoli, M., Marubio, L., McIntosh, J. M., & Changeux, J.-P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345
The role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309
Cytokines and the nervous system I: expression and recognition
HOPKINS, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93881-w · Cited by 306
Neuroprotection in Parkinson Disease: Mysteries, Myths, and Misconceptions
Schapira, A. H. V., & Olanow, C. W. (2004) · JAMA · doi:10.1001/jama.291.3.358 · Cited by 288
Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment
Ravina, B. M., Fagan, S. C., Hart, R. G., Hovinga, C. A., Murphy, D. D., Dawson, T. M., & Marler, J. R. (2003) · Neurology · doi:10.1212/01.wnl.0000058760.13152.1a · Cited by 262
Neuroprotective Strategies in Parkinson???s Disease: An Update on Progress
Mandel, S., Gr??nblatt, E., Riederer, P., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 237
Schwartz, R. D., Lehmann, J., & Kellar, K. J. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb02818.x · Cited by 235
Smoking and Parkinson’s disease: A dose–response relationship
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neurology · doi:10.1212/wnl.52.1.115 · Cited by 224
Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213
Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious
Baron, J. A. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011533 · Cited by 192
Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188
Smoking and Parkinson’s disease in twins
Tanner, C. M., Goldman, S. M., Aston, D. A., Ottman, R., Ellenberg, J., Mayeux, R., & Langston, J. W. (2002) · Neurology · doi:10.1212/wnl.58.4.581 · Cited by 182
The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration
O'Neill, M., Murray, T., Lakics, V., Visanji, N., & Duty, S. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339166 · Cited by 181
Nicotinic receptors in human brain: topography and pathology
Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00110-1 · Cited by 180
The effects of nicotine on Parkinson's disease.
Kelton, M., Kahn, H. J., Conrath, C. L., & NEWHOUSE, P. A. (2000) · PubMed · Cited by 180
Dajas-Bailador, F. A., Lima, P. A., & Wonnacott, S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00127-1 · Cited by 180
Smoking and Parkinson's disease.
Godwin-Austen, R. B., Lee, P. N., Marmot, M. G., & Stern, G. M. (1982) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.7.577 · Cited by 175
Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization
Quik, M., Polonskaya, Y., Gillespie, A., Jakowec, M., Lloyd, G. K., & Langston, J. W. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000911)425:1<58::aid-cne6>3.0.co;2-x · Cited by 172
Self-citationPresynaptic ionotropic receptors
McGehee, D. S., & Role, L. W. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80118-8 · Cited by 158
A Functional Role for Nicotine in Bcl2 Phosphorylation and Suppression of Apoptosis
Mai, H., May, W. S., Gao, F., Jin, Z., & Deng, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209044200 · Cited by 158
Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · PubMed · Cited by 158
Nicotine may relieve symptoms of Parkinson's disease
Fagerström, K. O., Pomerleau, O. F., Giordani, B., & Stelson, F. W. (1994) · Psychopharmacology · doi:10.1007/bf02244882 · Cited by 155
Soto‐Otero, R., Méndez‐Álvarez, E., Ameijeiras, Á. H., López-Real, A. M., & Labandeira-García, J. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01070-5 · Cited by 145
Involvement of the α3 Subunit in Central Nicotinic Binding Populations
Whiteaker, P., Peterson, C. G., Xu, W., McIntosh, J. M., Paylor, R. E., Beaudet, A. L., Collins, A. C., & Marks, M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02522.2002 · Cited by 145
Transdermal nicotine in PD: A randomized, double-blind, placebo-controlled study
Vieregge, A., Sieberer, M. G., Jacobs, H., Hagenah, J., & Vieregge, P. (2001) · Neurology · doi:10.1212/wnl.57.6.1032 · Cited by 143
Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics
Howard, L. A., Miksys, S. L., Hoffmann, E. B., Mash, D. C., & Tyndale, R. F. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705146 · Cited by 142
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
Quik, M., & Kulak, J. M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00036-0 · Cited by 141
Self-citationCosta, G., Abin-Carriquiry, J. A., & Dajas, F. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03087-0 · Cited by 134
Nicotine's oxidative and antioxidant properties in CNS
Newman, M. B., Arendash, G. W., Shytle, R. D., Bickford, P. C., Tighe, T., & Sanberg, P. R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02135-5 · Cited by 127
Effects of smoking in patients with early-onset Parkinson's disease
Ishikawa, A., & Miyatake, T. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90150-w · Cited by 116
Miksys, S. L., Hoffmann, E. B., & Tyndale, R. F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00281-1 · Cited by 116
Vulnerability of125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey
Quik, M., Polonskaya, Y., Kulak, J. M., & McIntosh, J. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05494.2001 · Cited by 114
Self-citationLemay, S., Chouinard, S., Blanchet, P. J., Masson, H., Soland, V., Beuter, A. C., & Bédard, M. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00172-6 · Cited by 107
Garrido, R., Mattson, M. P., Hennig, B., & Toborek, M. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00135.x · Cited by 102
Ebersbach, G., St�ck, M., M�ller, J., Wenning, G. K., Wissel, J., & Poewe, W. H. (1999) · Movement Disorders · Cited by 90
Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 86
Self-citationNicotine protects rat brain mitochondria against experimental injuries
Cormier, A., Morin, C., Zini, R., Tillement, J. P., & Lagrue, G. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00041-8 · Cited by 86
Fedele, E., Varnier, G., Ansaldo, M. A., & Raiteri, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702130 · Cited by 83
Matarredona, E. R., Santiago, M., Venero, J. L., Cano, J., & Machado, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00056.x · Cited by 81
Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum
Quik, M., Bordia, T., Forno, L. S., & McIntosh, J. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02177.x · Cited by 70
Self-citationGuan, Z., Nordberg, A. K., Mousavi, M. T., Rinne, J. O., & Hellström‐Lindahl, E. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03571-0 · Cited by 69
Jeyarasasingam, G., Tompkins, L., & Quik, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00488-2 · Cited by 69
Self-citationThe potential role of cotinine in the cognitive and neuroprotective actions of nicotine
Buccafusco, J. J., & Terry, A. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00226-1 · Cited by 68
Smoking and Parkinson's disease
Tzourio, C., Rocca, W. A., Breteler, M. M. B., Baldereschi, M., Dartigues, J.-F., Pousa, S. L., Manubens-Bertran, J. M., Alpérovitch, A., & the EUROPARKINSON Study Group (1997) · Neurology · doi:10.1212/wnl.49.5.1267 · Cited by 63
Schneider, J. S., Pope-Coleman, A., Velson, M. V., Menzaghi, F., & Lloyd, G. K. (1998) · Movement Disorders · doi:10.1002/mds.870130405 · Cited by 63
Castagnoli, K., & Murugesan, T. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00107-4 · Cited by 59
Dickerson, T. J., & Janda, K. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332847100 · Cited by 58
Kulak, J. M., McIntosh, J. M., & Quik, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.230 · Cited by 56
Self-citationStimulatory role of dopamine on fibroblast growth factor‐2 expression in rat striatum
Roceri, M., Molteni, R., Fumagalli, F., Racagni, G., Gennarelli, M., Corsini, G. U., Maggio, R., & Riva, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00088.x · Cited by 52
Obata, T., Aomine, M., Inada, T., & Kinemuchi, H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00737-1 · Cited by 27
Nicotinic Receptors in Human Brain
Schröder, H., Wevers, A., Birtsch, C., Ghobrial, M. W., Giacobini, E., & Maelicke, A. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_30 · Cited by 13
Cited by
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Metadata
- Authors
- Quik, M.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 27
- Issue
- 9
- Pages
- 561-568
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2004747758
- Cited by
- 324
- References
- 74
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.